BIO-Europe® has grown to be recognized as Europe’s flagship partnering event. In 2022, the event made its highly anticipated return to in-person, after a two-year hiatus due to the pandemic. The return was marked by impressive growth, making 2022 an important milestone in the event’s trajectory.
Now in its 29th edition, BIO-Europe will take place November 6–8, 2023 in Munich, Germany, and it is on track to be the largest yet. Current registration patterns not only support impressive growth, but they also reinforce the event’s international appeal: it is indeed ‘your gateway to the global biopharma community.’ Over 5,000 delegates will convene in Munich. They will be joined by an additional 800 delegates for digital partnering from November 14–15, 2023, hosted on partneringONE®.
Delegates at BIO-Europe will engage in over 27,000 one-to-one meetings to drive life science global dealmaking to new levels. Additionally, the event features one-of-a-kind networking opportunities, whether it is on the running trail, on the exhibit floor, or during an evening reception.
Leading pharma companies have confirmed their attendance with larger teams than in previous years, which represents an incomparable opportunity for biotech innovators to get their breakthroughs on the world stage. Pharma companies registered to date include Bayer, Boehringer Ingelheim, Ipsen, Johnson & Johnson, Eli Lilly & Co., Lonza, Merck, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Vetter Pharma, with others still to register.
Through three days of program sessions, attendees will learn the important trends and opportunities in the life sciences from some of the brightest minds in the sector. The agenda has been built around three themes: the Business of Biotech, Therapeutic Insights, and Ecosystem Innovation. Additionally, wellness activities will be scheduled throughout the event to keep attendees sharp for partnering and dealmaking.
One-to-one meetings at BIO-Europe are powered by partneringONE®, the gold standard solution for partnering meetings. Its advanced search capabilities allow delegates to pinpoint their ideal partners with ease and efficiency. Agenda sessions, company presentations and other event content will be uploaded to the platform for delegates to access at their convenience on demand. PartneringONE creates a seamless conference experience, allowing delegates to focus on their partnering strategies.
Global partnering is coming to Munich this November. A record number of attendees, a larger pharma presence, an inquiring program, a bustling exhibition, and informal networking opportunities at every turn. You must be there to experience it!
Portfolio Director, Europe
Claire Macht has 17 years of experience in biotech partnering, joining EBD Group in 2007. She has performed multiple roles at EBD, starting with partnering management, conference management, and program development. As Director, European Portfolio, she manages BIO-Europe, BIO-Europe Spring and BioEquity and works across the EBD Group team to deliver industry-leading partnering events.